1Robbins DC, Anderson L, Bowsher R, et al. Report of the American Diabetes Association's task force on standardization of the 9 insulin assay. Diabetes, 1996,45:242-256.
2Clark PM. Assays for insulin, proinsulin(s) and C-peptide. Ann Clin Bioehem, 1999,36:541-564.
3Zethelius B, Hales CN, Lithell HO, et al. Insulin resistance, impaired early insulin response, and insulin propeptides as predictors of the development of type 2 diabetes. Diabetes Care, 2004,2711433-1438.
4Alssema M, Dekker JM, Nijpels G, et al. Proinsulin concentration is an independent predictor of all-cause and cardiovascular mortality. Diabetes Care, 2005,28:860-865.
5Matsuda M, DeFronzo RA. Insulin sensitivity indices obtained from oral glucose tolerance testing: comparison with the euglycemic insulin clamp. Diabetes Care, 1999,22:1462-1470.
6Bonom E, Targher G, Alberlchic M, et al. Homeostasis model assessment closely mirrors the glucose clamp technique in the assessment of insulin sensitivity. Diabetes Care, 2000,23:57-63.
7Pfutzner A, Kunt T, Hohberg C, ct al. Fasting intact proinsulin is a highly specific predictor of insulin resistance in type 2 diabetes. Diabetes Care, 2004,27:682-687.
